Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2003
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624148 Synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of
09/23/2003US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
09/23/2003CA2275527C Novel heterocyclic substituted pyrrolidine amide derivatives
09/23/2003CA2244196C Dihydrobenzofuran compounds useful as anti-inflammatory agents
09/23/2003CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
09/23/2003CA2112907C Peptide which abrogates tnf and/or lps toxicity
09/23/2003CA2068027C Pharmaceutical compositions comprising an anticytokine
09/19/2003WO2002072077A2 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/19/2003CA2457192A1 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/18/2003WO2003076639A1 Osteoclast differentiation inhibitors
09/18/2003WO2003076638A1 Angiogenesis inhibitors
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides
09/18/2003WO2003076458A2 Selective dipeptide inhibitors of kallikrein
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076434A1 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
09/18/2003WO2003076433A1 Pyrimidine compounds
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076402A1 Therapeutic agent for pain
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003WO2003075953A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies
09/18/2003WO2003075935A1 Drugs containing riboflavin-type compounds
09/18/2003WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075926A1 Use of proton pump inhibitors for the treatment of airway disorders
09/18/2003WO2003075922A1 Nitrogen monoxide synthase inhibitors
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075909A1 Ibuprofen solution for hard shell capsules
09/18/2003WO2003075891A1 Dispersed solid-containing complex carbohydrate
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/18/2003WO2003075670A1 Treatment and prevention of inflammatory disorders
09/18/2003WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003051893A3 Improvements in pharmaceutical compositions
09/18/2003WO2003051807A3 Improvements in pharmaceutical compositions
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2003046135A3 Osteopontin-related compositions and methods
09/18/2003WO2003045360A3 Use of gaba for the treatment of intestinal inflammations
09/18/2003WO2003035007A3 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
09/18/2003WO2003024489A3 Combination of a nsaid and a pde-4 inhibitor
09/18/2003WO2003024419A3 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
09/18/2003WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
09/18/2003WO2002085410A3 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls
09/18/2003WO2002083700B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
09/18/2003WO2002078627A3 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176668 C-nitroso compounds and use thereof
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030176509 Methods and products related to 16-HETE analogs
09/18/2003US20030176505 Analgesic compositions comprising anti-epileptic compounds and methods of using same
09/18/2003US20030176498 Inhibitors of alpha4mediated cell adhesion
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176496 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof
09/18/2003US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176486 For use as an inhibitor of lipopolysaccharides (LPS)
09/18/2003US20030176481 Novel imidazole derivatives with anti-inflammatory activity
09/18/2003US20030176478 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
09/18/2003US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/18/2003US20030176470 For prophylaxis and/or therapy of skin diseases and/ or inflammation responses of the skin
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176460 Piperidine compounds for use as ccr-3 inhibitors
09/18/2003US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176451 Reacting a heterocyclic-methanesulfonyl substituted-quinazolineamine compound with amine compound
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176444 For therapy of inflammation
09/18/2003US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa
09/18/2003US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases
09/18/2003US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
1 ... 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 ... 1272